Jlk. Van Hove et al., One-methyl group metabolism in non-ketotic hyperglycinaemia: Mildly elevated cerebrospinal fluid homocysteine levels, J INH MET D, 21(8), 1998, pp. 799-811
Non-ketotic hyperglycinaemia (NKH) is a rare, severe brain disease caused b
y deficient glycine cleavage enzyme complex activity resulting in elevated
glycine concentrations. Recent experience suggests that factors in addition
to glycine kinetics are involved in its pathogenesis. The glycine cleavage
reaction through the formation of methylenetetrahydrofolate is an importan
t one-methyl group donor. A deficiency in one-methyl group metabolites, in
particular of choline, has been hypothesized in NKH. We investigated metabo
lites involved in one-methyl group metabolism in plasma and CSF of 8 patien
ts with NKH, and monitored the effect of treatment with choline in one pati
ent. Plasma and CSF choline and phosphatidylcholine concentrations were nor
mal, except for a low plasma choline in the single neonate studied. Choline
treatment did not change brain choline content, and was not associated wit
h clinical or radiological improvement. Methionine concentrations and, in o
ne-patient, S-adenosylmethionine and 5-methyltetrahydrofolate concentration
s were normal in CSF. Homocysteine concentrations in CSF, however, were sli
ghtly but consistently elevated in all four patients examined, but cysteine
, cysteinylglycine and glutathione were normal. Serine is important in the
transfer of one-methyl groups from mitochondria to cytosol. Serine concentr
ations were normal in plasma and CSF, but dropped to below normal in CSF in
three patients on benzoate treatment. These observations add to our unders
tanding of the complex metabolic disturbances in NKH.